Weight Loss and Obesity Treatment In addition to their role in managing type 2 diabetes, GLP-1 agonists have gained significant attention for their potential in promoting weight loss and treating obesity
Interestingly, hearing loss alone does not always cause tinnitus
Elevated Cardiovascular Risk In ARDs Patients with ARDs face heightened CV risk due to multiple factors: persistent inflammation, frequent use of glucocorticoids and NSAIDs, and higher prevalence of cardiometabolic conditions such as obesity, type 2 diabetes, and hypertension
But because theres so much drug company, pharmaceutical company money in this, theyre actually doing long-term trials and seeing that all these disease states improve or risk for chronic disease goes down with these drugs
Superparamagnetic iron oxide nanoparticles: amplifying ROS stress to improve anticancer drug efficacy